Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2024)Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.
Sectors & IndustriesHealthcare
Sector: Healthcare
| Ticker | Company | Country | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|
| ALIM | ALIMERA SCIENCES INC | United States | $176.96M | 52,354,450 | 29.08% | 70.92% | Net Buying | Net Selling |
| EUDA | EUDA HEALTH HOLDINGS LTD | Singapore | $45.56M | 24,627,509 | 4.34% | 39.80% | ||
| COCH | ENVOY MEDICAL INC | United States | $65.66M | 19,599,982 | 8.40% | 73.05% | Net Buying | |
| JAGX | JAGUAR HEALTH INC | United States | $85.35M | 276,216,260 | 0.45% | 3.48% | ||
| AXDX | ACCELERATE DIAGNOSTICS INC | United States | $18.85M | 21,664,387 | 3.44% | 96.56% | Net Buying | Net Selling |
| PSTV | PLUS THERAPEUTICS INC | United States | $9.58M | 4,276,082 | 0.60% | 99.40% | Net Buying | |
| NVAX | NOVAVAX INC | United States | $625.59M | 139,953,143 | 55.43% | 19.60% | Net Selling | Net Selling |
| MPLN | MULTIPLAN CORP | United States | $464.95M | 644,868,398 | 75.07% | 24.93% | Net Buying | Net Buying |
| BHC | BAUSCH HEALTH COMPANIES INC | Canada | $2.55B | 366,796,721 | 71.87% | 28.13% | Net Selling | Net Selling |
| MMA | ALTA GLOBAL GROUP LTD | Australia | N/A | 10,223,079 | 0.00% | 0.00% | ||
| AKAN | AKANDA CORP | United Kingdom | $804.70k | 8,842,851 | 0.67% | 0.00% | ||
| BDSX | BIODESIX INC | United States | $177.76M | 114,685,783 | 14.75% | 61.09% | Net Buying | Net Selling |
| KA | KINETA INC | United States | $6.85M | 10,962,460 | 3.76% | 96.24% | Net Buying | Net Buying |
| ALUR | ALLURION TECHNOLOGIES INC | United States | $101.93M | 47,852,203 | 15.87% | 16.54% | Net Buying | |
| ENGN | ENGENE HOLDINGS INC | Canada | $627.57M | 43,581,331 | 32.55% | 27.91% | Net Buying | Net Buying |
| ISPC | ISPECIMEN INC | United States | $2.69M | 9,978,958 | 3.92% | 64.70% | Net Buying | |
| HCWB | HCW BIOLOGICS INC | United States | $45.39M | 37,823,394 | 2.82% | 47.89% | Net Buying | Net Buying |
| CVM | CEL SCI CORP | United States | $75.66M | 50,104,231 | 12.96% | 43.88% | Net Buying | Net Buying |
| HUMA | HUMACYTE INC | United States | $538.26M | 119,083,728 | 14.97% | 36.38% | Net Selling | |
| ICCC | IMMUCELL CORP | United States | $41.00M | 7,750,864 | 13.45% | 24.31% | Net Buying | |
| EFTR | EFFECTOR THERAPEUTICS INC | United States | $10.07M | 4,704,409 | 18.84% | 81.16% | Net Selling | |
| DRMA | DERMATA THERAPEUTICS INC | United States | $2.16M | 6,660,840 | 4.01% | 95.99% | ||
| KPRX | KIORA PHARMACEUTICALS INC | United States | $12.73M | 26,256,197 | 1.15% | 47.24% | ||
| OPGN | OPGEN INC | United States | $4.71M | 10,013,524 | 1.28% | 98.72% | ||
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Israel | $18.12B | 1,132,640,597 | 51.18% | 0.96% | Net Selling | Net Selling |
| BTSG | BRIGHTSPRING HEALTH SERVICES INC | United States | $1.97B | 171,320,174 | 0.00% | 100.00% | Net Buying | Net Buying |
| ELAN | ELANCO ANIMAL HEALTH INC | United States | $8.50B | 494,181,620 | 90.53% | 9.47% | Net Selling | Net Selling |
| YS | YS BIOPHARMA CO LTD | China | $88.59M | 93,058,197 | 10.08% | 0.00% | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | United States | $341.85M | 50,420,315 | 5.85% | 51.39% | Net Buying | |
| GRTX | GALERA THERAPEUTICS INC | United States | $9.63M | 54,392,170 | 23.78% | 62.30% | Net Selling | Net Selling |
| ELTX | ELICIO THERAPEUTICS INC | United States | $97.24M | 10,235,469 | 3.25% | 92.54% | Net Buying | |
| ZVSA | ZYVERSA THERAPEUTICS INC | United States | $4.01M | 759,486 | 4.63% | 95.37% | ||
| MOVE | MOVANO INC | United States | $38.80M | 98,225,068 | 9.32% | 10.19% | Net Buying | |
| IBIO | IBIO INC | United States | $6.55M | 3,484,266 | 0.72% | 99.28% | Net Selling | |
| MAIA | MAIA BIOTECHNOLOGY INC | United States | $57.81M | 20,002,826 | 4.02% | 22.12% | Net Buying | Net Buying |
| ACXP | ACURX PHARMACEUTICALS INC | United States | $31.83M | 15,757,102 | 6.93% | 15.26% | Net Buying | |
| EHAB | ENHABIT INC | United States | $415.79M | 50,155,417 | 97.96% | 2.04% | Net Buying | Net Buying |
| CNTG | CENTOGENE NV | Germany | $10.98M | 27,595,835 | 9.75% | 0.00% | ||
| NUWE | NUWELLIS INC | United States | $4.96M | 18,051,055 | 1.18% | 68.58% | ||
| NRXP | NRX PHARMACEUTICALS INC | United States | $28.04M | 9,569,978 | 6.23% | 93.77% | Net Buying | |
| VCNX | VACCINEX INC | United States | $6.66M | 1,231,602 | 18.31% | 81.69% | Net Buying | Net Buying |
| AMRX | AMNEAL PHARMACEUTICALS INC | $2.00B | 308,651,373 | 25.23% | 74.77% | Net Selling | Net Selling | |
| TTOO | T2 BIOSYSTEMS INC | United States | $28.05M | 8,792,950 | 0.46% | 99.54% | Net Selling | |
| BCLI | BRAINSTORM CELL THERAPEUTICS INC | United States | $31.92M | 68,341,857 | 5.79% | 54.39% | Net Buying | Net Buying |
| PTN | PALATIN TECHNOLOGIES INC | United States | $37.92M | 16,136,640 | 8.26% | 91.74% | Net Selling | Net Selling |
| SKYE | SKYE BIOSCIENCE INC | United States | N/A | 28,062,907 | 0.00% | 100.00% | Net Buying | Net Buying |
| OTLK | OUTLOOK THERAPEUTICS INC | United States | $100.59M | 13,012,876 | 13.26% | 86.74% | Net Buying | Net Buying |
| ALLR | ALLARITY THERAPEUTICS INC | United States | $232.95k | 308,945 | 4.41% | 95.59% | ||
| CLRB | CELLECTAR BIOSCIENCES INC | United States | $104.52M | 32,260,510 | 26.67% | 12.70% | ||
| CNSP | CNS PHARMACEUTICALS INC | United States | $2.22M | 10,634,932 | 2.97% | 5.30% | Net Buying | |
| AKTX | AKARI THERAPEUTICS PLC | United States | $25.91M | 15,847,391,523 | 0.00% | 59.09% | ||
| QLGN | QUALIGEN THERAPEUTICS INC | United States | $1.78M | 6,307,371 | 0.87% | 99.13% | ||
| OWLT | OWLET INC | United States | $38.55M | 8,964,338 | 6.49% | 93.51% | Net Selling | Net Selling |
| PBH | PRESTIGE CONSUMER HEALTHCARE INC | United States | $3.49B | 49,649,288 | 68.97% | 31.03% | Net Selling | Net Selling |
| CHRO | CHROMOCELL THERAPEUTICS CORP | United States | $10.40M | 5,877,835 | 0.00% | 47.70% | Net Buying | Net Buying |
| ENSC | ENSYSCE BIOSCIENCES INC | United States | $3.97M | 7,329,172 | 0.72% | 57.99% | ||
| SLS | SELLAS LIFE SCIENCES GROUP INC | United States | $72.59M | 56,267,670 | 6.21% | 13.47% | Net Selling | |
| APTO | APTOSE BIOSCIENCES INC | Canada | $19.33M | 15,717,701 | 7.58% | 67.78% | Net Buying | |
| NRSN | NEUROSENSE THERAPEUTICS LTD | Israel | $18.05M | 15,379,042 | 0.92% | 0.00% | ||
| UNCY | UNICYCIVE THERAPEUTICS INC | United States | $37.54M | 34,756,436 | 37.49% | 18.00% | ||
| ARMP | ARMATA PHARMACEUTICALS INC | United States | $117.86M | 36,154,617 | 1.55% | 98.45% | ||
| IVA | INVENTIVA SA | France | $178.76M | 52,115,807 | 9.33% | 0.00% | ||
| AGEN | AGENUS INC | United States | $246.11M | 20,999,261 | 63.15% | 36.85% | Net Buying | Net Buying |
| LSDI | LUCY SCIENTIFIC DISCOVERY INC | Canada | $1.40M | 1,764,630 | 42.58% | 57.42% | ||
| GALT | GALECTIN THERAPEUTICS INC | United States | $201.19M | 61,903,672 | 8.36% | 91.64% | Net Buying | Net Selling |
| QTI | QT IMAGING HOLDINGS INC | United States | $18.22M | 21,437,216 | 8.17% | 91.83% | Net Buying | Net Buying |
| SCNI | SCINAI IMMUNOTHERAPEUTICS LTD | Israel | $1.88M | 1,453,970,784 | 0.03% | 0.05% | ||
| CDT | CONDUIT PHARMACEUTICALS INC | United States | $224.44M | 73,829,536 | 1.86% | 73.61% | ||
| XFOR | X4 PHARMACEUTICALS INC | United States | $178.85M | 167,937,781 | 57.63% | 1.30% | Net Selling | Net Selling |
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | United States | $59.75M | 27,918,560 | 18.78% | 38.25% | ||
| HCTI | HEALTHCARE TRIANGLE INC | United States | $5.12M | 4,649,909 | 0.02% | 99.98% | ||
| ANVS | ANNOVIS BIO INC | United States | $66.40M | 11,011,299 | 10.94% | 26.91% | Net Buying | |
| KTRA | KINTARA THERAPEUTICS INC | United States | $6.09M | 39,037,899 | 0.62% | 27.90% | ||
| RNXT | RENOVORX INC | United States | $22.68M | 16,865,975 | 1.96% | 20.25% | Net Buying | |
| OKYO | OKYO PHARMA LTD | United Kingdom | $38.59M | 25,553,274 | 0.15% | 99.85% | Net Buying | |
| MDAI | SPECTRAL AI INC | United States | $29.37M | 17,482,333 | 10.40% | 76.35% | Net Buying | |
| AMIX | AUTONOMIX MEDICAL INC | United States | $57.13M | 18,793,974 | 0.00% | 35.88% | ||
| BGXX | BRIGHT GREEN CORP | United States | $42.03M | 190,166,318 | 7.56% | 67.06% | Net Buying | Net Buying |
| ATNF | 180 LIFE SCIENCES CORP | United States | $1.74M | 852,772 | 7.45% | 92.55% | Net Buying | |
| ONMD | ONEMEDNET CORP | United Kingdom | $12.40M | 23,850,010 | 1.29% | 27.05% | Net Selling | |
| ONCO | ONCONETIX INC | United States | $2.50M | 22,327,701 | 10.85% | 21.37% | ||
| BCTX | BRIACELL THERAPEUTICS CORP | Canada | $36.12M | 15,981,726 | 15.42% | 12.34% | ||
| LIFW | MSP RECOVERY INC | United States | $120.37M | 139,966,718 | 0.48% | 13.43% | Net Buying | Net Selling |
| NLSP | NLS PHARMACEUTICS LTD | Switzerland | $5.03M | 35,671,780 | 16.35% | 0.00% | ||
| ICU | SEASTAR MEDICAL HOLDING CORP | United States | $32.51M | 75,419,458 | 1.23% | 19.86% | Net Buying | |
| INKT | MINK THERAPEUTICS INC | United States | $31.19M | 34,699,056 | 2.85% | 72.02% | Net Buying | Net Buying |
| NIVF | NEWGENIVF GROUP LTD | Thailand | $11.85M | 8,284,000 | 23.06% | 20.82% | ||
| PBM | PSYENCE BIOMEDICAL LTD | Canada | $14.73M | 13,390,659 | 3.69% | 66.53% | Net Selling | |
| CLDI | CALIDI BIOTHERAPEUTICS INC | United States | $8.24M | 35,538,034 | 5.35% | 49.17% | Net Selling | Net Buying |
| DHAI | DIH HOLDING US INC | United States | $66.49M | 40,544,935 | 5.83% | 46.79% | ||
| NKGN | NKGEN BIOTECH INC | United States | $28.51M | 22,805,643 | 15.84% | 84.16% | Net Buying | |
| OCEA | OCEAN BIOMEDICAL INC | United States | $59.42M | 34,149,046 | 13.42% | 75.32% | ||
| TVGN | TEVOGEN BIO HOLDINGS INC | United States | $163.13M | 164,614,418 | 1.46% | 96.20% | Net Selling |
Healthcare Industries
| Industry | Stocks | 1d % | 1w % | 1m % | 1y % | Zen Score | P/E ratio | P/B Ratio | ROE | ROA | ROCE | Upside/Downside | Consensus |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 680 | +0.27% | +0.15% | -3.35% | -19.81% | 5.22x | 5.97x | +20.11% | +3.25% | -34.29% | +81.85% | Strong Buy | ||
| 66 | +1.84% | +2.92% | -3.13% | +4.55% | 41.20x | 4.26x | -19.07% | +6.31% | +11.22% | +8.85% | Buy | ||
| 17 | +0.36% | +3.23% | +3.47% | +15.36% | 32.18x | 6.34x | +33.57% | +8.06% | +14.17% | +12.39% | Buy | ||
| 90 | +0.19% | -0.75% | +0.19% | -4.76% | -3.13x | 2.17x | +11.80% | +3.13% | +6.13% | +33.95% | Strong Buy | ||
| 12 | +1.46% | +3.08% | +2.17% | +1.80% | 24.92x | 3.00x | +15.14% | +4.72% | +11.74% | +13.72% | Buy | ||
| 59 | +0.16% | -0.86% | -7.21% | -22.00% | 11.32x | 3.38x | +6.90% | +2.41% | +5.80% | +35.30% | Buy | ||
| 51 | +1.67% | +3.36% | -0.08% | +11.10% | 41.62x | 4.45x | -94.32% | +6.72% | +13.98% | +14.51% | Buy | ||
| 153 | +1.92% | -0.56% | -4.95% | -13.26% | 30.45x | 3.74x | +7.39% | +5.30% | +7.85% | +21.24% | Buy | ||
| 9 | +1.30% | +1.74% | -0.82% | +29.77% | 26.60x | 109.30x | -10.08% | +3.43% | +19.54% | +10.08% | Buy | ||
| 56 | +1.36% | +1.41% | -2.83% | -8.83% | 57.92x | 3.56x | +11.31% | +7.73% | +10.12% | +19.23% | Buy |
Healthcare Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.